SELLAS Life Sciences Group Inc (NASDAQ: SLS) kicked off on Friday, down -4.71% from the previous trading day, before settling in for the closing price of $1.91. Over the past 52 weeks, SLS has traded in a range of $0.77-$2.48.
Healthcare Sector giant saw their annual sales surged by 45.94% over the last five years. While this was happening, its average annual earnings per share was recorded 41.33%. With a float of $124.57 million, this company’s outstanding shares have now reached $125.08 million.
The firm has a total of 15 workers. Let’s measure their productivity.
SELLAS Life Sciences Group Inc (SLS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of SELLAS Life Sciences Group Inc is 0.41%, while institutional ownership is 21.67%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.1 earnings per share (EPS), higher than consensus estimate (set at -0.13) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Take a look at SELLAS Life Sciences Group Inc’s (SLS) current performance indicators. Last quarter, stock had a quick ratio of 4.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Analysing the last 5-days average volume posted by the [SELLAS Life Sciences Group Inc, SLS], we can find that recorded value of 4.79 million was better than the volume posted last year of 2.75 million. As of the previous 9 days, the stock’s Stochastic %D was 16.42%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 34.65%, which indicates a significant increase from 1.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1843 in the past 14 days, which was higher than the 0.1320 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8533, while its 200-day Moving Average is $1.5812. Now, the first resistance to watch is $1.8967. This is followed by the second major resistance level at $1.9733. The third major resistance level sits at $2.0167. If the price goes on to break the first support level at $1.7767, it is likely to go to the next support level at $1.7333. Should the price break the second support level, the third support level stands at $1.6567.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
The company with the Market Capitalisation of 227.64 million has total of 125,079K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -30,880 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -6,600 K.
